PTX - Pernix Therapeutics Holdings, Inc.

NasdaqGM - NasdaqGM Delayed Price. Currency in USD
2.83
+0.07 (+2.54%)
At close: 3:59PM EDT
Stock chart is not supported by your current browser
Previous Close2.76
Open2.89
Bid2.66 x 500
Ask7.00 x 300
Day's Range2.83 - 2.92
52 Week Range1.83 - 7.15
Volume68,589
Avg. Volume156,415
Market Cap32.64M
Beta0.99
PE Ratio (TTM)-0.17
EPS (TTM)N/A
Earnings DateN/A
Forward Dividend & Yield0.00 (0.00%)
Ex-Dividend Date2001-08-21
1y Target EstN/A
Trade prices are not sourced from all markets
  • Capital Cube6 days ago

    ETFs with exposure to Pernix Therapeutics Holdings, Inc. : October 17, 2017

    Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to Pernix Therapeutics Holdings, Inc. Here are 5 ETFs with the largest exposure to PTX-US. Comparing the performance and risk of Pernix Therapeutics Holdings, Inc. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower ... Read more (Read more...)

  • Capital Cube2 months ago

    ETFs with exposure to Pernix Therapeutics Holdings, Inc. : August 18, 2017

    Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to Pernix Therapeutics Holdings, Inc. Here are 5 ETFs with the largest exposure to PTX-US. Comparing the performance and risk of Pernix Therapeutics Holdings, Inc. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower ... Read more (Read more...)

  • Thomson Reuters StreetEvents2 months ago

    Edited Transcript of PTX earnings conference call or presentation 27-Jul-17 8:30pm GMT

    Q2 2017 Pernix Therapeutics Holdings Inc Earnings Call

  • Capital Cube2 months ago

    ETFs with exposure to Pernix Therapeutics Holdings, Inc. : August 8, 2017

    Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to Pernix Therapeutics Holdings, Inc. Here are 5 ETFs with the largest exposure to PTX-US. Comparing the performance and risk of Pernix Therapeutics Holdings, Inc. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower ... Read more (Read more...)

  • Pernix Therapeutics Holdings, Inc. :PTX-US: Earnings Analysis: Q2, 2017 By the Numbers : August 1, 2017
    Capital Cube3 months ago

    Pernix Therapeutics Holdings, Inc. :PTX-US: Earnings Analysis: Q2, 2017 By the Numbers : August 1, 2017

    Categories: Yahoo FinanceGet free summary analysis Pernix Therapeutics Holdings, Inc. reports financial results for the quarter ended June 30, 2017. We analyze the earnings along side the following peers of Pernix Therapeutics Holdings, Inc. – Johnson & Johnson, Merck & Co., Inc., Eli Lilly and Company and GlaxoSmithKline plc Sponsored ADR (JNJ-US, MRK-US, LLY-US and GSK-US) that ... Read more (Read more...)

  • Capital Cube4 months ago

    ETFs with exposure to Pernix Therapeutics Holdings, Inc. : June 13, 2017

    Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to Pernix Therapeutics Holdings, Inc. Here are 5 ETFs with the largest exposure to PTX-US. Comparing the performance and risk of Pernix Therapeutics Holdings, Inc. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower ... Read more (Read more...)

  • Thomson Reuters StreetEvents5 months ago

    Edited Transcript of PTX earnings conference call or presentation 15-May-17 8:30pm GMT

    Q1 2017 Pernix Therapeutics Holdings Inc Earnings Call

  • Pernix Therapeutics Holdings, Inc. :PTX-US: Earnings Analysis: Q1, 2017 By the Numbers : May 19, 2017
    Capital Cube5 months ago

    Pernix Therapeutics Holdings, Inc. :PTX-US: Earnings Analysis: Q1, 2017 By the Numbers : May 19, 2017

    Categories: Yahoo FinanceGet free summary analysis Pernix Therapeutics Holdings, Inc. reports financial results for the quarter ended March 31, 2017. We analyze the earnings along side the following peers of Pernix Therapeutics Holdings, Inc. – Cumberland Pharmaceuticals Inc., Johnson & Johnson, Eli Lilly and Company, Pfizer Inc., Merck & Co., Inc., Emergent BioSolutions Inc., Lannett Company, Inc., ... Read more (Read more...)

  • Capital Cube5 months ago

    ETFs with exposure to Pernix Therapeutics Holdings, Inc. : May 16, 2017

    Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to Pernix Therapeutics Holdings, Inc. Here are 5 ETFs with the largest exposure to PTX-US. Comparing the performance and risk of Pernix Therapeutics Holdings, Inc. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower ... Read more (Read more...)

  • Capital Cube6 months ago

    ETFs with exposure to Pernix Therapeutics Holdings, Inc. : May 4, 2017

    Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to Pernix Therapeutics Holdings, Inc. Here are 5 ETFs with the largest exposure to PTX-US. Comparing the performance and risk of Pernix Therapeutics Holdings, Inc. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower ... Read more (Read more...)

  • Capital Cube7 months ago

    ETFs with exposure to Pernix Therapeutics Holdings, Inc. : April 7, 2017

    Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to Pernix Therapeutics Holdings, Inc. Here are 5 ETFs with the largest exposure to PTX-US. Comparing the performance and risk of Pernix Therapeutics Holdings, Inc. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower ... Read more (Read more...)

  • Pernix Therapeutics Holdings, Inc. :PTX-US: Earnings Analysis: Q4, 2016 By the Numbers : April 5, 2017
    Capital Cube7 months ago

    Pernix Therapeutics Holdings, Inc. :PTX-US: Earnings Analysis: Q4, 2016 By the Numbers : April 5, 2017

    Categories: Yahoo FinanceGet free summary analysis Pernix Therapeutics Holdings, Inc. reports financial results for the quarter ended December 31, 2016. Highlights Summary numbers: Revenues of USD 30.17 million, Net Earnings of USD -86.08 million. Gross margins narrowed from 7.90% to 1.37% compared to the same period last year, operating (EBITDA) margins now -16.59% from 11.05%. Change in ... Read more (Read more...)

  • Thomson Reuters StreetEvents7 months ago

    Edited Transcript of PTX earnings conference call or presentation 28-Mar-17 8:30pm GMT

    Q4 2016 Pernix Therapeutics Holdings Inc Earnings Call

  • GuruFocus.com7 months ago

    Pernix: An Investor's Rationale to Staying Long

    The stock has fallen a bit, but there's a good reason investors are staying long

  • Capital Cube9 months ago

    ETFs with exposure to Pernix Therapeutics Holdings, Inc. : January 20, 2017

    Categories: ETFs Yahoo Finance Click here to see latest analysis ETFs with exposure to Pernix Therapeutics Holdings, Inc. Here are 5 ETFs with the largest exposure to PTX-US. Comparing the performance and risk of Pernix Therapeutics Holdings, Inc. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower ... Read more (Read more...)

  • Pernix Therapeutics Holdings, Inc. :PTX-US: Earnings Analysis: Q3, 2016 By the Numbers : January 5, 2017
    Capital Cube10 months ago

    Pernix Therapeutics Holdings, Inc. :PTX-US: Earnings Analysis: Q3, 2016 By the Numbers : January 5, 2017

    Categories: Yahoo Finance Get free summary analysis Pernix Therapeutics Holdings, Inc. reports financial results for the quarter ended September 30, 2016. Highlights Summary numbers: Revenues of USD 41.47 million, Net Earnings of USD -26.44 million. Gross margins widened from 22.31% to 23.94% compared to the same period last year, operating (EBITDA) margins now 16.33% from 12.71%. Change in ... Read more (Read more...)

  • Thomson Reuters StreetEventslast year

    Edited Transcript of PTX earnings conference call or presentation 11-Aug-16 8:30pm GMT

    Q2 2016 Pernix Therapeutics Holdings Inc Earnings Call